Betaxolol-d7 hydrochloride
Betaxolol-d7 (hydrochloride) is the deuterium labeled Betaxolol hydrochloride. Betaxolol Hydrochloride is a selective beta1 adrenergic receptor blocker that can be used for the research of hypertension and glaucoma.
For research use only. We do not sell to patients.
- CAS No.: 1219802-92-2
- Formula: C18H23D7ClNO3
- Molecular Weight:350.93
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-103254
ML221Apelin (APJ) Receptor Antagonist -
HY-B0580C
Ketorolac hemicalciumCOX Inhibitor -
HY-100806S
Kynurenic acid-d5Stable Isotope -
HY-B0341S
Nicorandil-d4Stable Isotope -
HY-103254R
ML221 (Standard)Reference Standard -
HY-B0577
LatanoprostProstaglandin Receptor Agonist -
HY-B0916S
Propoxur-d3Stable Isotope -
HY-B0311AS
Carbidopa-d3 monohydrateStable Isotope -
HY-70057S1
Safinamide-d4-1Stable Isotope -
HY-127143
Sterculic acidSCD1 Inhibitor -
HY-B0601
Tafluprost acidFP Receptor Agonist -
HY-148292
C16-Sphingosine-1-phosphateEDG/S1P Receptor Ligand
All Adrenergic Receptor Isoforms
More
Biological Activity
Description
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 1219802-92-2
-
Unlabeled CAS 63659-19-8
-
Molecular Weight 350.93
-
Formula C18H23D7ClNO3
-
SMILES
[2H]C([2H])([2H])C(C([2H])([2H])[2H])([2H])NCC(O)COC1=CC=C(C=C1)CCOCC2CC2.[H]Cl
-
Synonyms
SL75212-d7
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
Purity & Documentation
References
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
[2]. Rudoy, C.A. and E.J. Van Bockstaele, Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry, 2007. 31(5 [Content Brief]
[3]. Lesar, T.S., Comparison of ophthalmic beta-blocking agents. Clin Pharm, 1987. 6(6): p. 451-63. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Betaxolol-d7 hydrochloride Related Classifications
HY-B0381AS Related Classifications
Powered by Bioz